Two Sigma Advisers’s Cyclacel Pharmaceuticals CYCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3
| Closed | -$6.79K | – | 2440 |
|
|
2023
Q1 | $6.79K | Sell |
3
-2
| -40% | -$4.53K | ﹤0.01% | 2560 |
|
|
2022
Q4 | $11.1K | Sell |
5
-1
| -17% | -$2.21K | ﹤0.01% | 2455 |
|
|
2022
Q3 | $29K | Buy |
6
+1
| +20% | +$4.83K | ﹤0.01% | 2419 |
|
|
2022
Q2 | $18K | Hold |
5
| – | – | ﹤0.01% | 2557 |
|
|
2022
Q1 | $54K | Sell |
5
-14
| -74% | -$151K | ﹤0.01% | 2583 |
|
|
2021
Q4 | $263K | Sell |
19
-15
| -44% | -$208K | ﹤0.01% | 2181 |
|
|
2021
Q3 | $640K | Buy |
34
+31
| +1,033% | +$584K | ﹤0.01% | 1824 |
|
|
2021
Q2 | $70K | Buy |
+3
| New | +$70K | ﹤0.01% | 2366 |
|